Get the Stockscreener App
6.08
1.37%
-0.010
After Hours:
6.05
-0.03
-0.49%
Lensar Inc stock is traded at $6.08, with a volume of 24,147.
It is down -1.37% in the last 24 hours and up +18.01% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
See More
Previous Close:
$6.09
Open:
$6.1
24h Volume:
24,147
Relative Volume:
0.21
Market Cap:
$73.65M
Revenue:
$57.70M
Net Income/Loss:
$11.98M
P/E Ratio:
-10.58
EPS:
-0.5746
Net Cash Flow:
$-12.24M
1W Performance:
+3.57%
1M Performance:
+18.01%
6M Performance:
-41.96%
1Y Performance:
-55.70%
1-Day Range:
$5.92
$6.10
1-Week Range:
$5.78
$6.12
52-Week Range:
$5.06
$13.74
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
6.085 | 73.72M | 57.70M | 11.98M | -12.24M | -0.5746 |
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-26 | Upgrade | Lake Street | Hold → Buy |
| Mar-18-26 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
Lensar Stock Rallies Into Memorial Day Break — Why Tuesday’s Open Matters - Bez Kabli
LNSR Earnings Overview 2026-05-22Crowd Stock Picks - Newser
LENSAR Inc. (LNSR) Gains 1.2% as Shares Test Key Resistance ZoneCommunity Watchlist Picks - Newser
LENSAR (LNSR) Up +3.57% — 3 Reasons the Rally Could Continue 2026-05-21Zero Gamma Level - Newser
LENSAR Inc stock (US52633C1071): FDA clearance for ALLY lowers capital requirements for eye surgeons - AD HOC NEWS
LENSAR (LNSR) Gains +1.38% — Support Holds at $5.59 2026-05-20Dark Pool Prints - Newser
Liquidity Mapping Around (LNSR) Price Events - Stock Traders Daily
What LENSAR (LNSR)'s +1.62% Jump Means for Investors 2026-05-18Community Pattern Alerts - Newser
LENSAR stock (US52633C1071): eye-surgery specialist back in focus after Alcon deal collapse - AD HOC NEWS
LENSAR Inc stock (US52634T1034): laser eye surgery specialist in focus after latest business updates - AD HOC NEWS
LENSAR signals 2027 as really, really good year as it rebuilds distributor orders after Alcon deal termination - MSN
Q1 2026 LENSAR Inc Earnings Call Transcript - GuruFocus
Brandes Investment Partners (NASDAQ: LNSR) holds 1.03M shares, 8.48% - Stock Titan
Earnings call transcript: LENSAR Q1 2026: EPS Miss, Stock Rises on Revenue Stability - Investing.com Nigeria
[144] LENSAR, Inc. SEC Filing - Stock Titan
All News for LNSR : LENSAR - Zacks Investment Research
MSN Money - MSN
LENSAR Q1 earnings call highlights - MSN
LENSAR (NASDAQ:LNSR) Announces Quarterly Earnings Results - MarketBeat
LENSAR (LNSR) CEO reports Form 4 update with 992,096 shares unchanged - Stock Titan
LENSAR (LNSR) COO sees 2,739 shares withheld to cover RSU tax bill - Stock Titan
LENSAR (NASDAQ: LNSR) CFO has shares withheld for RSU tax obligations - Stock Titan
LENSAR Q1 Earnings Call Highlights - sharewise.com
One-time gains drive Lensar (NASDAQ: LNSR) to $36.3M quarterly profit - Stock Titan
Earnings call transcript: LENSAR Q1 2026 shows resilience despite revenue dip - Investing.com Nigeria
Earnings call transcript: LENSAR Q1 2026 shows resilience despite revenue dip By Investing.com - Investing.com South Africa
LENSAR, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Lensar 1Q Rev $13.4M >LNSR - Moomoo
LENSAR Inc (NASDAQ:LNSR) Q1 2026 Revenue Misses Estimates as ALLY System Backlog Grows - ChartMill
LENSAR ($LNSR) Releases Q1 2026 Earnings - Quiver Quantitative
LENSAR® Reports First Quarter 2026 Results and Provides Business Update - The Manila Times
LENSAR reports Q1 2026: Revenue $13.4M, Recurring Revenue $12.6M, Net Income $36.3M - TradingView
What separates LENSAR (LNSR) from the pack? (Slight Loss) 2026-05-08Most Discussed Stocks - Newser
Why (LNSR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
LENSAR (LNSR) price target decreased by 32.00% to 8.67 - MSN
LENSAR, INC. Executive Compensation, Board of Directors, and Corporate Governance Overview (2025) - Minichart
LNSR LENSAR reports wider-than-expected Q4 2025 EPS loss, triggering a 2.97 percent drop in share price today. - Newser
LENSAR (NASDAQ: LNSR) updates 10-K with governance, pay and control data - Stock Titan
LENSAR® to Report First Quarter 2026 Results on May 8, 2026 - The Manila Times
Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN
LENSAR (LNSR) Expected to Announce Earnings on Thursday - MarketBeat
LENSAR sets May 8 update on its cataract-laser business - Stock Titan
Understanding Momentum Shifts in (LNSR) - Stock Traders Daily
LENSAR (LNSR) price target decreased by 16.67% to 12.75 - MSN
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lensar Inc Stock (LNSR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| STAAB THOMAS R II | Chief Financial Officer |
Mar 19 '26 |
Option Exercise |
2.65 |
5,500 |
14,575 |
175,959 |
1.35%
2.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):